DX-2730

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameDX-2730
Drug Alias NameDX-2712DX-2730M0131-A06-GA-S
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMatrix metalloproteinase 12 inhibitors
TargetsMatrix metalloproteinase 12
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyax Corp
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A